Jill M. Wagner

2.0k citations

24 papers · 1.5k indexed · h-index 18

Co-authors: Larry M. Karnitz Masahiko Kobayashi Sinny Delacroix Ken-ichi Yamamoto Gerald J. Gleich Scott H. Kaufmann Gail M. Kephart Amelia M. Huehls
Topics: DNA Repair Mechanisms (10 papers)Eosinophilic Disorders and Syndromes (7 papers)PARP inhibition in cancer therapy (7 papers)
Cited by: Oncology Molecular Biology Immunology and Allergy
Journals: Journal of Biological Chemistry Genes & Development PLoS ONE
Partner nations: United States Denmark Sweden

In The Last Decade

Jill M. Wagner

24 papers receiving 1.5k citations

Peers

Countries citing papers authored by Jill M. Wagner

Since Specialization

Citations

This map shows the geographic impact of Jill M. Wagner's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jill M. Wagner with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jill M. Wagner more than expected).

Fields of papers citing papers by Jill M. Wagner

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jill M. Wagner. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jill M. Wagner. The network helps show where Jill M. Wagner may publish in the future.

Co-authorship network of co-authors of Jill M. Wagner

This figure shows the co-authorship network connecting the top 25 collaborators of Jill M. Wagner. A scholar is included among the top collaborators of Jill M. Wagner based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jill M. Wagner. Jill M. Wagner is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	CHFR and Paclitaxel Sensitivity of Ovarian Cancer 2021 ·Cancers ·Andrea E. Wahner Hendrickson,Daniel W. Visscher,Xiaonan Hou,Krista M. Goergen,(unknown),Thomas G. Beito,Vivian Negron,Wilma L. Lingle,Amy K. Bruzek,Rachel M. Hurley,Jill M. Wagner,Karen S. Flatten,Kevin L. Peterson,Paula A. Schneider,Melissa C. Larson,Matthew J. Maurer,Kimberly R. Kalli,Ann L. Oberg,S. John Weroha,Scott H. Kaufmann	2
2	Genomically Incorporated 5-Fluorouracil that Escapes UNG-Initiated Base Excision Repair Blocks DNA Replication and Activates Homologous Recombination 2015 ·Molecular Pharmacology ·Amelia M. Huehls,Catherine J. Huntoon,Poorval Joshi,Carly Baehr,Jill M. Wagner,Xiaoxiao Wang,Marietta Y. Lee,Larry M. Karnitz	42
3	Identification of DNA Repair Pathways That Affect the Survival of Ovarian Cancer Cells Treated with a Poly(ADP-Ribose) Polymerase Inhibitor in a Novel Drug Combination 2012 ·Molecular Pharmacology ·Amelia M. Huehls,Jill M. Wagner,Catherine J. Huntoon,Larry M. Karnitz	31
4	Poly(ADP-Ribose) Polymerase Inhibition Synergizes with 5-Fluorodeoxyuridine but not 5-Fluorouracil in Ovarian Cancer Cells 2011 ·Cancer Research ·Amelia M. Huehls,Jill M. Wagner,Catherine J. Huntoon,Liyi Geng,Charles Erlichman,Anand G. Patel,Scott H. Kaufmann,Larry M. Karnitz	42
5	Cisplatin-Induced DNA Damage Activates Replication Checkpoint Signaling Components that Differentially Affect Tumor Cell Survival 2009 ·Molecular Pharmacology ·Jill M. Wagner,Larry M. Karnitz	104
6	Overcoming S-Phase Checkpoint-Mediated Resistance: Sequence-Dependent Synergy of Gemcitabine and 7-Ethyl-10-hydroxycamptothecin (SN-38) in Human Carcinoma Cell Lines 2008 ·Molecular Pharmacology ·Marina Gálvez‐Peralta,Nga T. Dai,David A. Loegering,Karen S. Flatten,Stephanie L. Safgren,Jill M. Wagner,Matthew M. Ames,Larry M. Karnitz,Scott H. Kaufmann	9
7	Pharmacological Abrogation of S-Phase Checkpoint Enhances the Anti-Tumor Activity of Gemcitabine In Vivo 2007 ·Cell Cycle ·David J. Matthews,(unknown),Jason Chen,(unknown),Lester M. Bornheim,Douglas O. Clary,Albert Tai,Jill M. Wagner,Nicole Miller,(unknown),Scott Robertson,(unknown),Larry M. Karnitz	109
8	The Rad9–Hus1–Rad1 (9–1–1) clamp activates checkpoint signaling via TopBP1 2007 ·Genes & Development ·Sinny Delacroix,Jill M. Wagner,Masahiko Kobayashi,Ken-ichi Yamamoto,Larry M. Karnitz	364
9	Chaperoning Checkpoint Kinase 1 (Chk1), an Hsp90 Client, with Purified Chaperones 2005 ·Journal of Biological Chemistry ·Sonnet J.H. Arlander,Sara J. Felts,Jill M. Wagner,Bridget Stensgard,David O. Toft,Larry M. Karnitz	70
10	Gemcitabine-Induced Activation of Checkpoint Signaling Pathways That Affect Tumor Cell Survival 2005 ·Molecular Pharmacology ·Larry M. Karnitz,Karen S. Flatten,Jill M. Wagner,David A. Loegering,Jennifer S. Hackbarth,Sonnet J.H. Arlander,Benjamin T. Vroman,(unknown),(unknown),Kevin M. Hopkins,Howard B. Lieberman,Junjie Chen,William A. Cliby,Scott H. Kaufmann	108
11	Localization of Eosinophil–Derived Neurotoxin and Eosinophil Cationic Protein in Neutrophilic Leukocytes 1999 ·International Archives of Allergy and Immunology ·Sanjiv Sur,Dohn G. Glitz,Hirohito Kita,(unknown),Ellen A. Peterson,Deborah A. Weiler,Gail M. Kephart,Jill M. Wagner,Terry J. George,Gerald J. Gleich,Kristin M. Leiferman	21
12	A Novel and Highly Divergent Homolog of Human Eosinophil Granule Major Basic Protein 1999 ·Journal of Biological Chemistry ·Douglas A. Plager,David A. Loegering,Deborah A. Weiler,James L. Checkel,Jill M. Wagner,Nigel J. Clarke,Stephen Naylor,(unknown),Larry L. Thomas,(unknown),Ben Cocks,Susan G. Stuart,Gerald J. Gleich	59
13	The proform of eosinophil major basic protein: a new maternal serum marker for Down syndrome 1999 ·Prenatal Diagnosis ·Michael Christiansen,Claus Oxvig,Jill M. Wagner,Qiuping Qin,Tri Huu Nguyen,Michael T. Overgaard,Severin Olesen Larsen,Lars Sottrup‐Jensen,Gerald J. Gleich,Bent Nørgaard‐Pedersen	24
14	Placental site trophoblastic tumor: Human placental lactogen and pregnancy-associated major basic protein as immunohistologic markers 1998 ·Human Pathology ·Alice Rhoton-Vlasak,Jill M. Wagner,Joanne L. Rutgers,Rebecca N. Baergen,Robert H. Young,Patrick C. Roche,Timothy B. Plummer,Gerald J. Gleich	19
15	Eosinophil infiltration and degranulation in normal human tissue 1998 ·The Anatomical Record ·Masahiko Katô,Gail M. Kephart,Nicholas J. Talley,Jill M. Wagner,(unknown),Motoki Bonno,Thomas W. McGovern,Gerald J. Gleich	162
16	Allergen challenge in asthma: association of eosinophils and lymphocytes with interleukin‐5 1995 ·Allergy ·Sanjiv Sur,Gerald J. Gleich,Kenneth P. Offord,Mark C. Swanson,Toshio Ohnishi,Lisa Martin,Jill M. Wagner,Deborah A. Weiler,Loren W. Hunt	17
17	Identification of Angiotensinogen and Complement C3dg as Novel Proteins Binding the Proform of Eosinophil Major Basic Protein in Human Pregnancy Serum and Plasma 1995 ·Journal of Biological Chemistry ·Claus Oxvig,Jesper Haaning,Lene Juel Kristensen,Jill M. Wagner,Inger Rubin,Torgny Stigbrand,Gerald J. Gleich,Lars Sottrup‐Jensen	62
18	Tissue eosinophilia induced by recombinant human interleukin‐5 in the hamster cheek pouch membrane 1995 ·Mediators of Inflammation ·Michael Minnicozzi,Walter N. Durán,Donghyun Kim,Gerald J. Gleich,Jill M. Wagner,Robert W. Egan	1
19	Analysis of pregnancy-associated major basic protein levels throughout gestation 1993 ·Placenta ·Jill M. Wagner,Kathleen R. Bartemes,(unknown),Sandra L. Dunnette,Kenneth P. Offord,James L. Checkel,Gerald J. Gleich	43
20	Plasma levels of eosinophil granule major basic protein in pregnant cynomolgus monkeys 1992 ·Placenta ·Terri Wasmoen,Jill M. Wagner,Kathleen R. Bartemes,Gerald J. Gleich	1

About Jill M. Wagner

Jill M. Wagner is a scholar working on Rheumatology, Process Chemistry and Technology and Immunology and Allergy, having authored 24 papers that have together received 1.5k indexed citations. Recurring topics across this work include DNA Repair Mechanisms (10 papers), Eosinophilic Disorders and Syndromes (7 papers) and PARP inhibition in cancer therapy (7 papers). The work is most often cited by research in Oncology (494 citations), Molecular Biology (915 citations) and Immunology and Allergy (75 citations). Jill M. Wagner has collaborated with scholars based in United States, Denmark and Sweden. Frequent co-authors include Larry M. Karnitz, Masahiko Kobayashi, Sinny Delacroix, Ken-ichi Yamamoto, Gerald J. Gleich, Scott H. Kaufmann, Gail M. Kephart, Amelia M. Huehls, Catherine J. Huntoon and Nicholas J. Talley. Their work appears in journals such as Journal of Biological Chemistry, Genes & Development and PLoS ONE.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact